Tg Therapeutics (TGTX) Times Interest Earned (2011 - 2026)
Tg Therapeutics' (TGTX) quarterly Times Interest Earned came in at $4.54 in Q1 2026, up 255.71% year-on-year from $1.28 in Q1 2025, and down 41.28% quarter-over-quarter from $7.73 in Q4 2025.
Tg Therapeutics (TGTX) Times Interest Earned (2011 - 2026) Analysis & Trends
Tg Therapeutics' Times Interest Earned history runs 15 years deep, the most recent figure standing at $4.54 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 255.71% year-over-year to $4.54 in Q1 2026; TTM through Mar 2026 was $5.4, a 82.14% increase from a year earlier, with the FY2025 full-year figure at $1.28, up 215.48% from the prior year.
- Times Interest Earned retreated to $4.54 in Q1 2026 per TGTX's latest filing, from $7.73 in the prior quarter.
- Across five years, Times Interest Earned topped out at $19.79 in Q3 2023 and bottomed at -$13.01 in Q1 2023.
- The 5-year median for Times Interest Earned is $0.94 (2024), against an average of $0.01.
- Across the five-year window, Times Interest Earned plunged 421.96% in 2023 and jumped 713.87% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$12.34 in 2022, then soared by 171.6% to $8.84 in 2023, then slumped by 71.71% to $2.5 in 2024, then surged by 209.17% to $7.73 in 2025, then tumbled by 41.28% to $4.54 in 2026.
- Per Business Quant, the three latest TGTX Times Interest Earned figures stand at $4.54 (Q1 2026), $7.73 (Q4 2025), and $2.66 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 4.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.54 |
| Dec 31, 2025 | 7.73 |
| Sep 30, 2025 | 2.66 |
| Jun 30, 2025 | 5.19 |
| Mar 31, 2025 | 1.28 |
| Dec 31, 2024 | 2.50 |
| Sep 30, 2024 | 0.94 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | 8.84 |
| Sep 30, 2023 | 19.79 |
| Jun 30, 2023 | -11.76 |
| Mar 31, 2023 | -13.01 |
| Dec 31, 2022 | -12.34 |
| Sep 30, 2022 | -5.83 |
| Jun 30, 2022 | -2.25 |
| Mar 31, 2022 | -8.09 |
| Dec 31, 2021 | -31.61 |
| Sep 30, 2021 | -4.72 |
| Jun 30, 2021 | -11.30 |